Pathogenic potentials of bacterial proteases.
暂无分享,去创建一个
[1] H. Maeda,et al. Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases. , 1989, The Journal of biological chemistry.
[2] H. Maeda,et al. Molecular mechanism of complex infection by bacteria and virus analyzed by a model using serratial protease and influenza virus in mice , 1989, Journal of virology.
[3] H. Maeda,et al. Cytotoxicity of bacterial proteases in various tumor cells mediated through alpha 2-macroglobulin receptor. , 1989, Cancer research.
[4] H. Maeda,et al. Characterization of 73 kDa thiol protease from Serratia marcescens and its effect on plasma proteins. , 1988, Journal of Biochemistry (Tokyo).
[5] H. Maeda,et al. Interdomain cleavage of plasma fibronectin by zinc-metalloproteinase from Serratia marcescens. , 1988, Biochimica et biophysica acta.
[6] H. Maeda,et al. Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens , 1988, Infection and immunity.
[7] H. Maeda,et al. Pathogenic capacity of proteases from Serratia marcescens and Pseudomonas aeruginosa and their suppression by chicken egg white ovomacroglobulin , 1987, Infection and immunity.
[8] H. Maeda,et al. Internalization of serratial protease into cells as an enzyme-inhibitor complex with alpha 2-macroglobulin and regeneration of protease activity and cytotoxicity. , 1987, The Journal of biological chemistry.
[9] H. Klenk,et al. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. , 1987, Virology.
[10] H. Maeda,et al. Antitumor activity of some bacterial proteases: eradication of solid tumors in mice by intratumor injection. , 1987, Cancer research.
[11] H. Maeda,et al. Different binding kinetics of Serratia 56K protease with plasma alpha 2-macroglobulin and chicken egg white ovomacroglobulin. , 1987, Journal of biochemistry.
[12] K. Matsumoto,et al. Enhancement of vascular permeability upon serratial infection: activation of Hageman factor--kallikrein--kinin cascade. , 1986, Advances in experimental medicine and biology.
[13] H. Maeda,et al. Degradation of protease inhibitors, immunoglobulins, and other serum proteins by Serratia protease and its toxicity to fibroblast in culture , 1986, Infection and immunity.
[14] L. F. Kress. Inactivation of human plasma serine proteinase inhibitors (serpins) by limited proteolysis of the reactive site loop with snake venom and bacterial metalloproteinases , 1986, Journal of cellular biochemistry.
[15] E. J. Miller,et al. Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase , 1986, Infection and immunity.
[16] H. Maeda,et al. The serratial 56K protease as a major pathogenic factor in serratial keratitis. Clinical and experimental study. , 1985, Ophthalmology.
[17] S. Pizzo,et al. Binding and endocytosis of alpha 2-macroglobulin-plasmin complexes. , 1985, Biochemistry.
[18] H. Maeda,et al. A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs , 1985, Infection and immunity.
[19] R. Baltimore,et al. IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis. , 1985, The Journal of infectious diseases.
[20] J. Tournier,et al. In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase , 1985, Infection and immunity.
[21] J. Gee,et al. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. , 1984, The Journal of clinical investigation.
[22] H. Maeda,et al. Purification and characterization of four proteases from a clinical isolate of Serratia marcescens kums 3958 , 1984, Journal of bacteriology.
[23] H. Maeda,et al. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease. , 1984, Journal of biochemistry.
[24] A. Kreger,et al. Importance of serratia protease in the pathogenesis of experimental Serratia marcescens pneumonia , 1983, Infection and immunity.
[25] R. Hy,et al. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody? , 1983 .
[26] G. Bodey,et al. Infections caused by Pseudomonas aeruginosa. , 1983, Reviews of infectious diseases.
[27] A. Ikai,et al. Alpha-2-macroglobulin-like protease inhibitor from the egg white of cuban crocodile (Crocodylus rhombifer). , 1983, Journal of biochemistry.
[28] J. Travis,et al. Inactivation of human plasma alpha 1-proteinase inhibitor by a metalloproteinase from Serratia marcescens. , 1982, Biochimica et biophysica acta.
[29] A. Kreger,et al. Characterization of rabbit corneal damage produced by Serratia keratitis and by a serratia protease , 1981, Infection and immunity.
[30] H. Tsuzuki,et al. Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor , 1979, Infection and immunity.
[31] D. Nagel,et al. Serratia arthritis. Report of seven cases. , 1976, The Journal of bone and joint surgery. American volume.
[32] K. Miller,et al. Elastase of Pseudomonas aeruginosa: Inactivation of Complement Components and Complement-Derived Chemotactic and Phagocytic Factors , 1974, Infection and immunity.
[33] S. I. Brown,et al. The cornea-destroying enzyme of Pseudomonas aeruginosa. , 1974, Investigative ophthalmology.
[34] D. Maki,et al. Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study. , 1973, The Journal of infectious diseases.
[35] P. Ward,et al. Generation by Bacterial Proteinases of Leukotactic Factors from Human Serum, and Human C3 and C5 , 1973, The Journal of Immunology.
[36] K. Morihara. PRODUCTION OF ELASTASE AND PROTEINASE BY PSEUDOMONAS AERUGINOSA , 1964, Journal of bacteriology.